Fastest customizable press release news feed in the world
– Business combination transaction with BCTG Acquisition Corp., a special purpose acquisition company sponsored by Boxer Capital, completed today – – Combined company Tango Therapeutics, Inc. will be listed on the Nasdaq Capital Market under ticker symbol "TNGX" – – Total expected cash position of approximately $515 million including gross proceeds from transaction totaling approximately $342 million, combining funds held in BCTG's trust account and PIPE financing once completed – CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. ("Tango Therapeutics" or "Tango"), a biotechnology company committed to discovering and delivering the next generation of prec
- Leading institutional investors commit $186 million through a common stock private investment in public equity ("PIPE") led by Boxer Capital - Total proceeds expected to be approximately $353 million, combining funds held in trust by BCTG Acquisition Corp and the PIPE financing - Merger expected to be completed in third quarter of 2021, and Combined Company will be listed on Nasdaq under the ticker "TNGX" – - Joint investor conference call to discuss the proposed transaction today, Wednesday, April 14, at 10:00 a.m. ET – Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. (NA
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
S-8 - Tango Therapeutics, Inc. (0001819133) (Filer)
424B3 - Tango Therapeutics, Inc. (0001819133) (Filer)
EFFECT - Tango Therapeutics, Inc. (0001819133) (Filer)
424B3 - Tango Therapeutics, Inc. (0001819133) (Filer)
S-1 - Tango Therapeutics, Inc. (0001819133) (Filer)
8-K - Tango Therapeutics, Inc. (0001819133) (Filer)
424B3 - BCTG Acquisition Corp. (0001819133) (Filer)
EFFECT - BCTG Acquisition Corp. (0001819133) (Filer)
S-4/A - BCTG Acquisition Corp. (0001819133) (Filer)
S-4/A - BCTG Acquisition Corp. (0001819133) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)
SC 13D - Tango Therapeutics, Inc. (0001819133) (Subject)
SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)
SC 13D - Tango Therapeutics, Inc. (0001819133) (Subject)
SC 13G - BCTG Acquisition Corp. (0001819133) (Subject)